201 related articles for article (PubMed ID: 6472419)
1. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis.
Gurney ME; Belton AC; Cashman N; Antel JP
N Engl J Med; 1984 Oct; 311(15):933-9. PubMed ID: 6472419
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis.
Smith RG; Hamilton S; Hofmann F; Schneider T; Nastainczyk W; Birnbaumer L; Stefani E; Appel SH
N Engl J Med; 1992 Dec; 327(24):1721-8. PubMed ID: 1331790
[TBL] [Abstract][Full Text] [Related]
3. Suppression of sprouting at the neuromuscular junction by immune sera.
Gurney ME
Nature; 1984 Feb 9-15; 307(5951):546-8. PubMed ID: 6694745
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses.
Westarp ME; Fuchs D; Bartmann P; Hoff-Jörgensen R; Clausen J; Wachter H; Kornhuber HH
Eur J Med; 1993; 2(6):327-32. PubMed ID: 8252177
[TBL] [Abstract][Full Text] [Related]
5. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
[TBL] [Abstract][Full Text] [Related]
6. Axonal excitability properties in amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2006 Jul; 117(7):1458-66. PubMed ID: 16759905
[TBL] [Abstract][Full Text] [Related]
7. Proceedings: Suppression of botulinum toxin-induced axonal sprouting in skeletal muscle by implantation of an extra nerve.
Duchen LW; Rogers M; Stolkin C; Tonge DA
J Physiol; 1975 Jun; 248(1):1P-2P. PubMed ID: 1151797
[No Abstract] [Full Text] [Related]
8. Growth of skeletal muscle from patients with amyotrophic lateral sclerosis transplanted into nude mice.
Gulati AK; Rivner MH; Shamsnia M; Swift TR; Sohal GS
Muscle Nerve; 1988 Jan; 11(1):33-8. PubMed ID: 3340099
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.
Siklós L; Engelhardt J; Harati Y; Smith RG; Joó F; Appel SH
Ann Neurol; 1996 Feb; 39(2):203-16. PubMed ID: 8967752
[TBL] [Abstract][Full Text] [Related]
10. Motor nerve sprouting in human orbicularis muscle after botulinum A injection.
Holds JB; Alderson K; Fogg SG; Anderson RL
Invest Ophthalmol Vis Sci; 1990 May; 31(5):964-7. PubMed ID: 2335457
[TBL] [Abstract][Full Text] [Related]
11. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
[TBL] [Abstract][Full Text] [Related]
12. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition.
Tamura N; Kuwabara S; Misawa S; Kanai K; Nakata M; Sawai S; Hattori T
Clin Neurophysiol; 2006 Nov; 117(11):2451-8. PubMed ID: 16996798
[TBL] [Abstract][Full Text] [Related]
13. A molecular genetic approach to amyotrophic lateral sclerosis.
Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
[TBL] [Abstract][Full Text] [Related]
14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
15. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
16. [Serum myoglobulin levels in neuromuscular diseases].
Verbitskiĭ AM; Shagal DI; Rozhinskaia IV; Rott GM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1614-7. PubMed ID: 3434055
[TBL] [Abstract][Full Text] [Related]
17. Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgG.
Demestre M; Howard RS; Orrell RW; Pullen AH
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):141-56. PubMed ID: 16599943
[TBL] [Abstract][Full Text] [Related]
18. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
[TBL] [Abstract][Full Text] [Related]
19. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis.
Bradley WG; Good P; Rasool CG; Adelman LS
Ann Neurol; 1983 Sep; 14(3):267-77. PubMed ID: 6195954
[TBL] [Abstract][Full Text] [Related]
20. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.
Schaefer AM; Sanes JR; Lichtman JW
J Comp Neurol; 2005 Sep; 490(3):209-19. PubMed ID: 16082680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
